Skip to main content
. 2017 Mar 29;2017(1):hox003. doi: 10.1093/hropen/hox003

Table I.

Regulations, indications, and funding for OoC in 2015 for 27 European countries.

Country Specific regulation ART register Indications for freezing Funding
General OoC* Age (years) Medical Non-medical Medical Non-medical
Austria Law Yes No No Yes Forbidden No No
Belarus No No No No Yes No No No
Belgium No Yes Yes <45 No No Yes No
Bulgaria No No No No Yes Yes No No
Czech Republic No Yes No No No No Yes No
Denmark Law Yes 2016 <46 Yes No Yes No
Estonia No No No No No No No No
Finland Law Yes No No No Yes Yes No
France Law/COP Yes 2017 18–42 Yes Forbidden** Yes No
Germany Law/COP Yes Yes 20–49 Yes Yes No No
Greece No No No No No No No No
Hungary Law Yes No No Yes No No No
Italy Law Yes 2016 No Yes Yes Yes No
Ireland No No No No No No Yes No
Lithuania No No No No No No No No
Malta Law/COP Yes No 25–42 Yes Forbidden Yes No
Netherlands Law/COP No 2016 No Yes Yes Yes No
Norway Law Yes No No Yes No Yes No
Romania COP Yes No No No No No No
Russia No No No No Yes No No No
Slovakia No No No No No No No No
Slovenia Law No No <45 Yes No Yes No
Spain Law Yes No >18 No No Yes No
Sweden No Yes No No No No Yes No
Switzerland Law/COP Yes No No No No No No
UK Law/COP Yes No No No No Yes No
Ukraine No No No No Yes Yes No No

OoC, oocyte cryopreservation; COP, code of practice.

*Dates later than 2015 mean a specific registry is planned (putative date in italics).

**Except for childless egg donors who may self cryo-preserve some oocytes since 2016.